Filing Details
- Accession Number:
- 0001209191-20-045698
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-07 17:41:33
- Reporting Period:
- 2020-08-05
- Accepted Time:
- 2020-08-07 17:41:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645460 | Cue Biopharma Inc. | CUE | Pharmaceutical Preparations (2834) | 473324577 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739130 | Anish Suri | C/O Cue Biopharma, Inc. 21 Erie Street Cambridge MA 02139 | President And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-05 | 800 | $6.42 | 35,358 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-05 | 800 | $20.01 | 34,558 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-05 | 800 | $0.00 | 800 | $6.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 145,000 | 2029-03-06 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020.
- This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019.
Billionaire Hedge Funds
